Quarterly report · Q2
8095.TEDINET S100RE4A
Period2022-12-01 → 2023-05-31
Filed2023-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.9bn | 2022-12-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥208m | 2022-12-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥284m | 2022-12-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥68m | 2022-12-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥228m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥236m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥64.8bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.2bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.6bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.4bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.3bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥804m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.0bn | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥639m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.78 | 2022-12-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.55 | 2023-03-01 → 2023-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.9% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥669,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-05-31 | −¥49m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-05-31 | ¥18m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥7.8bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥559m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥84m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥8.9bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥8.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥56m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥79m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥81m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥6.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥191m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥326m |
| —segment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| —segment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥840m |
| —segment total | segment profit | 2022-12-01 → 2023-05-31 | ¥239m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥841m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-05-31 | ¥190m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 636
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | CurrentQuarterInstant | 38201834000 | JPY |
| Capital stock | Prior1YearInstant | 4557400000 | JPY |
| Capital stock | CurrentQuarterInstant | 4581397000 | JPY |
| Capital surplus | Prior1YearInstant | 6538828000 | JPY |
| Capital surplus | CurrentQuarterInstant | 6569700000 | JPY |
| Retained earnings | Prior1YearInstant | 15031853000 | JPY |
| Retained earnings | CurrentQuarterInstant | 14433056000 | JPY |
| Treasury stock | Prior1YearInstant | -531722000 | JPY |
| Treasury stock | CurrentQuarterInstant | -525817000 | JPY |
| Shareholders equity | Prior1YearInstant | 25596360000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 25058337000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1007002000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1105590000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -4026000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | 563000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 191067000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 222428000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 196203000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 133450000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1390246000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 1462033000 | JPY |
| Non controlling interests | Prior1YearInstant | 82094000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 106656000 | JPY |
| Net assets | Prior1YearInstant | 27068701000 | JPY |
| Net assets | CurrentQuarterInstant | 26627028000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 63551819000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 64828862000 | JPY |
| Net sales | Prior1YTDDuration | 24934991000 | JPY |
| Net sales | CurrentYTDDuration | 26857511000 | JPY |
| Cost of sales | Prior1YTDDuration | 16782199000 | JPY |
| Cost of sales | CurrentYTDDuration | 19008028000 | JPY |
| Gross profit | Prior1YTDDuration | 8152791000 | JPY |
| Gross profit | CurrentYTDDuration | 7849482000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 7432742000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 7641147000 | JPY |
| Operating income | Prior1YTDDuration | 720049000 | JPY |
| Operating income | CurrentYTDDuration | 208334000 | JPY |
| Interest income noi | Prior1YTDDuration | 1215000 | JPY |
| Interest income noi | CurrentYTDDuration | 1007000 | JPY |
| Dividends income noi | Prior1YTDDuration | 27451000 | JPY |
| Dividends income noi | CurrentYTDDuration | 29190000 | JPY |
| Rent income noi | Prior1YTDDuration | 8896000 | JPY |
| Rent income noi | CurrentYTDDuration | 7171000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 49518000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 1330000 | JPY |
| Other noi | Prior1YTDDuration | 90448000 | JPY |
| Other noi | CurrentYTDDuration | 105942000 | JPY |
| Non operating income | Prior1YTDDuration | 177530000 | JPY |
| Non operating income | CurrentYTDDuration | 144642000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 26931000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |